Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Xeris Pharmaceuticals Inc (XERS)

Xeris Pharmaceuticals Inc (XERS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 203,734
  • Shares Outstanding, K 66,363
  • Annual Sales, $ 20,440 K
  • Annual Income, $ -91,140 K
  • 60-Month Beta 1.86
  • Price/Sales 10.44
  • Price/Cash Flow N/A
  • Price/Book 4.27
Trade XERS with:

Options Overview

Details
  • Implied Volatility 56.48%
  • Historical Volatility 48.48%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 258.28% on 08/17/20
  • IV Low 56.48% on 07/30/21
  • Put/Call Vol Ratio 0.02
  • Today's Volume 475
  • Volume Avg (30-Day) 912
  • Put/Call OI Ratio 0.10
  • Today's Open Interest 48,692
  • Open Int (30-Day) 61,817

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.31
  • Number of Estimates 2
  • High Estimate -0.27
  • Low Estimate -0.34
  • Prior Year -0.63
  • Growth Rate Est. (year over year) +50.79%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.03 +1.32%
on 07/30/21
4.33 -29.10%
on 07/02/21
-1.00 (-24.57%)
since 06/30/21
3-Month
2.94 +4.42%
on 06/01/21
4.98 -38.35%
on 06/25/21
-0.76 (-19.84%)
since 04/30/21
52-Week
2.73 +12.45%
on 07/31/20
7.94 -61.34%
on 02/08/21
+0.17 (+5.86%)
since 07/30/20

Most Recent Stories

More News
Xeris Pharmaceuticals Provides Announcement Under the Irish Takeover Rules for Relevant Securities in Issue

Xeris Pharmaceuticals, Inc. (Nasdaq: XERS) (Xeris) today announced in accordance with Rule 2.10 of the Irish Takeover Panel Act, 1997, Takeover Rules 2013 (the Irish Takeover Rules) that, as of the close...

XERS : 3.07 (-3.15%)
Xeris Pharmaceuticals to Announce Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 5, 2021

Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use injectable drug formulations,...

XERS : 3.07 (-3.15%)
Xeris Pharmaceuticals Announces Executive Changes as Part of Its Strategy to Position the Company for Long-Term Commercial Success

--Steve Pieper, VP of Finance, assumes the role of CFO

XERS : 3.07 (-3.15%)
Xeris Pharmaceuticals Enters Into an Exclusive License and Supply Agreement with Tetris Pharma Limited to Commercialize Ogluo(R) in Europe

--Agreement covers 32 countries

XERS : 3.07 (-3.15%)
Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable drug formulations, today announced...

XERS : 3.07 (-3.15%)
Implied Volatility Surging for Xeris Pharmaceuticals (XERS) Stock Options

Investors need to pay close attention to Xeris Pharmaceuticals (XERS) stock based on the movements in the options market lately.

XERS : 3.07 (-3.15%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ALTA, XERS, ONB, FFWM; Shareholders are Encouraged to Contact the Firm

Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

GBCI : 51.56 (-1.00%)
ALTA : 40.39 (-1.66%)
XERS : 3.07 (-3.15%)
ONB : 16.09 (-1.11%)
FFWM : 23.57 (+0.30%)
Lifshitz Law Firm, P.C. Announces Investigation of CLDR, DTRCD, DCRN, ENVB, PACX, SNX, XERS, and SBBP

/PRNewswire/ --

CLDR : 15.87 (+0.19%)
DTRCD : 5.6500 (-2.85%)
DCRN : 9.86 (-0.20%)
ENVB : 1.9100 (-2.55%)
PACX : 9.92 (+0.30%)
SNX : 119.54 (+0.05%)
XERS : 3.07 (-3.15%)
SBBP : 2.39 (-3.63%)
Thinking about buying stock in Senseonics, Xeris Pharmaceuticals, Purple Biotech, Targa Resources, or BlackBerry?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SENS, XERS, PPBT, TRGP, and BB.

SENS : 3.07 (+0.66%)
PPBT : 5.52 (-1.25%)
XERS : 3.07 (-3.15%)
BB : 10.16 (-1.84%)
TRGP : 42.11 (-1.91%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates TLND, XERS, SNX, FI, HGV, STAY; Shareholders are Encouraged to Contact the Firm

, /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

TLND : 65.97 (+0.02%)
XERS : 3.07 (-3.15%)
SNX : 119.54 (+0.05%)
FI : 2.75 (-1.43%)
HGV : 40.67 (-0.42%)
STAY : 20.46 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Xeris Pharmaceuticals, Inc. produces peptides, proteins, antibodies, molecules, auto-injectors, multi-dose pens and infusion pumps to treat endocrine and metabolic diseases. The company's proprietary formulation technologies consist of XeriSol (TM) and XeriJect(TM). Xeris Pharmaceuticals, Inc. is based...

See More

Key Turning Points

3rd Resistance Point 3.31
2nd Resistance Point 3.25
1st Resistance Point 3.16
Last Price 3.07
1st Support Level 3.00
2nd Support Level 2.94
3rd Support Level 2.85

See More

52-Week High 7.94
Fibonacci 61.8% 5.95
Fibonacci 50% 5.34
Fibonacci 38.2% 4.72
Last Price 3.07
52-Week Low 2.73

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar